157
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review

, , ORCID Icon &
Pages 181-197 | Received 02 Sep 2023, Accepted 16 Jan 2024, Published online: 10 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.